While some animal models (mice and zebrafish) expressing these gain-of-function mutations (Table 1) have demonstrated skeletal dysplasia-like phenotypes somewhat similar to the human diseases [102,119], these models still do not fully recapitulate the variety of TRPV4-induced disease presentation observed in human patients. This evidence concerns the gene TRPV4 and skeletal dysplasia.